First trimester screening: The BUN study

Seminars in Perinatology

Volumn 29, Issue 4, 2005, Pages 236-239

  Wapner, Ronald J ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

BLOOD ANALYSIS; CONFERENCE PAPER; DOWN SYNDROME; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HUMAN; MATERNAL SERUM; MEDICAL ASSESSMENT; MEDICAL SPECIALIST; PRENATAL SCREENING; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING TEST; SECOND TRIMESTER PREGNANCY; SEQUENTIAL ANALYSIS; TRISOMY 18; TRISOMY 21;

ADULT; CHORIONIC GONADOTROPIN; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; FETAL DISEASES; HUMANS; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 23644447739     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2005.05.013     Document Type: Conference Paper

References (14)

1. D.A. Krantz, J.W. Larsen, P.D. Buchanan First-trimester Down syndrome screening free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A Am J Obstet Gynecol 174 1996 612 616
2. R.J.M. Snijders, P. Noble, N. Sebire UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation Lancet 352 1998 343 346
3. D.A. Krantz, T.W. Hallahan, F. Orlandi First trimester Down syndrome screening using dried blood biochemistry and nuchal translucency Obstet Gynecol 96 2000 207 213
4. R.J. Wapner, E.A. Thom, J.L. Simpson First trimester aneuploid screening results of a North American multicenter study N Engl J Med 349 2003 1405 1413
5. J.N. Macri, R.W. Anderson, D.A. Krantz Prenatal maternal dried blood screening with alpha-fetoprotein and free beta-human chorionic gonadotropin for open neural tube defect and Down syndrome Am J Obstet Gynecol 174 1996 566 572
6. J.E. Haddow, G.E. Palomaki, G.E. Knight Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening N Engl J Med 330 1994 1114 1118
7. F.D. Malone, N.J. Wald, J.A. Canick First and second trimester evaluation of risk (FASTER) Trial principal results of the NICHD multicenter Down syndrome screening study Am J Obstet Gynecol 189 2003 1
8. N.J. Wald, C. Rodeck, A.K. Hackshaw First and second trimester antenatal screening for Down's syndrome the results of the serum, urine and ultrasound screening study (SURUSS) Health Tech Assess 7 2003 1 77
9. K. Spencer, C.E. Spencer, M. Power Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic a review of three years prospective experience Br J Obstet Gynecol 110 2003 281 286
10. R.J.M. Snijders, E.A. Thom, J.M. Zachary First-trimester trisomy screening nuchal translucency measurement training and quality assurance to correct and unify technique Ultrasound Obstet Gynecol 19 2002 353 359
11. L.D. Platt, N. Greene, A. Johnson Sequential pathways of testing after first-trimester screening for trisomy 21 Am J Obstet Gynecol 104 2004 661 666
12. N.J. Wald, H.C. Watt, A.K. Hackshaw Integrated screening for Down's syndrome based on tests performed during the first and second trimesters N Engl J Med 341 1999 461 467
13. D.E. Wright, I. Bradbury, P. Benn Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening Prenat Diagn 24 2004 762 766
14. R.O. Bahado-Singh, J. Zachacy, R.J. Wapner Elevated first trimester nuchal translucency measurement is associated with an increased risk of congenital heart defect Am J Obstet Gynecol 189 2004 S78 56